Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1997 1
1999 1
2007 1
2008 1
2013 2
2014 2
2015 7
2016 10
2017 13
2018 20
2019 24
2020 17
2021 6
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 33004319

98 results

Results by year

Filters applied: . Clear all
Page 1
Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.
Desai A, Escamilla-Ocanas C, Dilip D, Saber H, Damani R. Desai A, et al. J Stroke Cerebrovasc Dis. 2021 Apr;30(4):105654. doi: 10.1016/j.jstrokecerebrovasdis.2021.105654. Epub 2021 Feb 10. J Stroke Cerebrovasc Dis. 2021. PMID: 33578352
Percutaneous Coronary Intervention Without Interruption of Oral Anticoagulation.
Córdoba-Soriano JG, Oteo JF, Gutiérrez-Díez A, Escudero-Díaz A, Gallardo-López A, Portero-Portaz JJ, Salinas P, Pérez-Pereira E, Melehi D, Jiménez-Mazuecos J. Córdoba-Soriano JG, et al. Circ Cardiovasc Interv. 2021 Feb;14(2):e009949. doi: 10.1161/CIRCINTERVENTIONS.120.009949. Epub 2021 Feb 5. Circ Cardiovasc Interv. 2021. PMID: 33541101 No abstract available.
Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial.
Nicolau JC, Bhatt DL, Hohnloser SH, Kimura T, Lip GYH, Miede C, Nordaby M, Oldgren J, Steg PG, Ten Berg JM, Godoy LC, Cannon CP; RE-DUAL PCI Steering Committee and Investigators. Nicolau JC, et al. Drugs. 2020 Jul;80(10):995-1005. doi: 10.1007/s40265-020-01323-x. Drugs. 2020. PMID: 32562206 Free PMC article. Clinical Trial.
98 results